ForFarmers results for the first half of 2026: Continued strong results and further market share growth

ForFarmers reported H1 2026 earnings strength: gross profit rose 12.6% to €327.3m, underlying EBITDA increased 39.3% to €84.7m, and underlying net profit jumped 59.4% to €37.3m. Operating volume grew 5.1% YoY and ROACE (underlying EBIT) improved to 22.0% from 14.3% a year earlier, supported by higher volumes and improved gross margin. The company also received Polish competition authority approval for its joint venture with KPS, strengthening its position in the Polish poultry market, with transaction completion expected in fall; ForFarmers plans to update financial targets at a Capital Markets Day later in the year.

Analysis

This reads like a quality inflection, not just a quarter beat: the business is converting modest volume growth into much faster EBITDA because scale is finally showing up in gross margin. That tends to compress the valuation gap versus other agri-input names, while pressuring smaller regional feed mills that cannot match procurement, logistics density, or customer retention. The Poland JV matters more than the headline suggests: it gives the company a platform to consolidate poultry-related feed demand where fragmented competitors are more exposed to pricing pressure.

Near term, the stock can keep grinding higher into the fall JV close and year-end capital markets update, because investors usually re-rate a name when management proves the margin step-up is durable and backed by cash, not just pricing. The key falsifier is if input costs re-accelerate faster than feed pricing, or if the reported volume strength proves to be channel fill rather than true share gain by the next trading update. With leverage low, balance-sheet risk is muted; the real risk is multiple compression if growth normalizes faster than consensus expects.

Contrarian take: the market may be underestimating how much of this is self-help and consolidation option value rather than a pure cyclical rebound. If that is right, the rerating can persist 6-18 months, especially if the company uses its cash headroom for accretive M&A. But if the Polish approval becomes a slower-than-expected integration story, the upside becomes a one-quarter earnings pop rather than a durable re-rating.

Key Decisions for Investors

• If the correct listing is FFARM.AS, buy on a 2-4% post-print pullback and look for a 10-15% re-rating into the year-end Capital Markets Day; thesis breaks if Q3 volume turns negative on a like-for-like basis or gross margin compresses by >150 bps.
• Treat JYNT as a data mismatch and do not force a trade off this release; wait for the correct security mapping before expressing the view.
• Set a calendar alert for the fall Poland JV close: if integration language is smooth and no regulatory delay appears, add on weakness; if closing slips or synergies are qualified, trim into strength.
• Relative-value idea: long FFARM.AS versus a weaker European agri-input or regional feed peer once a liquid pair is available; best risk/reward is 1-3 months after estimates are revised, not on the opening gap.
• Watch the next grain/input-cost print and livestock herd data as the main falsifiers; if feed input inflation re-accelerates faster than selling prices, take profits and reduce exposure.